Liliane Rosa Alves Manaças

5PUBLICATIONS
10CO-AUTHORS
Gene and molecular therapyMetabolic medicineCardiology (incl. cardiovascular diseases)Cancer therapy (excl. chemotherapy and radiation therapy)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 05, 2026
Real-World Effectiveness, Safety, and Adverse Event Kinetics of Pembrolizumab in Advanced Melanoma within the Brazilian Public Health System.

Hildeneide Rocha Lima, Mahanna Vanzeler Vaz, Rebeka Caribé Badin

|Aug 13, 2025
Time-Driven Activity-Based Costing (TDABC) applied in a chemotherapy department of a public reference oncology hospital.

Amanda Oliveira Serra-Campos, Camila Campos Valério, Liliane Rosa Alves Manaças

|Feb 29, 2024
Evaluation of hematological changes and immune response biomarkers as a prognostic factor in critical patients with COVID-19.

Liliane Rosa Alves Manaças, Robson Luís Oliveira de Amorim, Alian Aguila

|Oct 13, 2022
Management of chemotherapy-induced febrile neutropenia and use of granulocyte colony-stimulating factor in patients with soft tissue or bone sarcoma.

Raphaele Teixeira Mazzaro, Mahanna Vanzeler Vaz, Rebeka Caribé Badin

|Apr 11, 2022
Pharmacological profile and potential drug interactions in ovarian cancer hospitalized patients.

Rebeka Caribé Badin, Carolina Souza Machado Martins, Liliane Rosa Alves Manaças

Pageof 1

Frequent Collaborators

2 joint publications

Rebeka Caribé Badin

2 joint publications

Rodrigo Saar da Costa

1 joint publications

Carolina Souza Machado Martins

1 joint publications

Raphaele Teixeira Mazzaro